News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
356,893 Results
Type
Article (14321)
Company Profile (128)
Press Release (342444)
Section
Business (112558)
Career Advice (449)
Deals (18592)
Drug Delivery (25)
Drug Development (31127)
Employer Resources (49)
FDA (8784)
Job Trends (7659)
News (172628)
Policy (12346)
Tag
Academia (1314)
Alliances (34537)
Alzheimer's disease (429)
Approvals (8761)
Artificial intelligence (111)
Bankruptcy (129)
Best Places to Work (6405)
Biotechnology (97)
Breast cancer (40)
Cancer (399)
Career advice (400)
Cell therapy (124)
Clinical research (23654)
Collaboration (222)
COVID-19 (1107)
C-suite (43)
Data (370)
Diagnostics (4680)
Drug discovery (39)
Earnings (37393)
Employer resources (42)
Events (49825)
Executive appointments (123)
FDA (8984)
Funding (169)
Gene editing (46)
Gene therapy (83)
GLP-1 (181)
Government (1221)
Healthcare (9806)
Infectious disease (1139)
Inflammatory bowel disease (47)
Interviews (48)
IPO (7901)
Job creations (1433)
Job search strategy (358)
Layoffs (108)
Legal (2506)
Lung cancer (57)
Manufacturing (82)
Medical device (11275)
Medtech (11280)
Mergers & acquisitions (10736)
Metabolic disorders (98)
Neuroscience (506)
NextGen Class of 2024 (3526)
Non-profit (1511)
Northern California (536)
Obesity (53)
Opinion (65)
Patents (58)
People (32088)
Phase I (8717)
Phase II (10708)
Phase III (6920)
Pipeline (96)
Postmarket research (501)
Preclinical (3960)
Press Release (66)
Radiopharmaceuticals (147)
Rare diseases (76)
Real estate (3346)
Regulatory (9015)
Research institute (1265)
Resumes & cover letters (66)
Southern California (538)
Startups (2499)
United States (5601)
Vaccines (228)
Date
Last 7 days (344)
Last 30 days (1390)
Last 365 days (19374)
2024 (15717)
2023 (22096)
2022 (30813)
2021 (32513)
2020 (30541)
2019 (25798)
2018 (19463)
2017 (18871)
2016 (17766)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (314)
Arizona (92)
Asia (23549)
Australia (4098)
California (1257)
Canada (598)
China (98)
Colorado (72)
Connecticut (56)
Europe (47973)
Florida (199)
Georgia (62)
Illinois (149)
Indiana (79)
Kansas (75)
Maryland (264)
Massachusetts (901)
Michigan (126)
Minnesota (156)
New Hampshire (54)
New Jersey (408)
New York (365)
North Carolina (358)
Northern California (536)
Ohio (62)
Pennsylvania (287)
South America (504)
Southern California (538)
Texas (189)
Utah (45)
Washington State (188)
356,893 Results for "dbv technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
DBV Technologies to Participate in Upcoming ACAAI 2024 Congress
October 21, 2024
·
5 min read
Business
DBV Technologies Reports First Quarter 2024 Financial Results and Business Update
DBV Technologies reported financial results for the first quarter 2024.
May 7, 2024
·
10 min read
DBV Technologies to Participate in Upcoming May 2024 Investor Conferences
DBV Technologies announced Daniel Tassé, Chief Executive Officer, will deliver a company presentation at two investor conferences in May.
May 9, 2024
·
2 min read
DBV Technologies Announces Results of its 2024 Combined General Meeting
DBV Technologies, a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, held its Combined General Meeting.
May 16, 2024
·
2 min read
Press Releases
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
September 24, 2024
·
5 min read
DBV Technologies to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
DBV Technologies announced that Daniel Tassé, Chief Executive Officer, will participate in a fireside chat at the 45th Annual Goldman Sachs Global Healthcare Conference on Monday, June 10th, at 8:00 am EDT, as well as in one-on-one investor meetings.
June 5, 2024
·
2 min read
DBV Technologies Announces Plan to Implement ADS Ratio Change
DBV Technologies announced plans to change the ratio of its American Depositary Shares to its ordinary shares, nominal value €0.10 per share, from the current ADS Ratio of one ADS to one-half of one ordinary share to a new ADS Ratio of one ADS to one ordinary share.
May 17, 2024
·
5 min read
DBV Technologies to Participate in Upcoming AAAAI 2024 Congress
DBV Technologies announced two presentations at the American Academy of Allergy, Asthma, and Immunology Annual Meeting, February 23-26 in Washington, D.C.
February 20, 2024
·
6 min read
DBV Technologies Reports Full Year 2023 Financial Results and Business Update
DBV Technologies, a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need, reported financial results for the full year 2023.
March 7, 2024
·
12 min read
Press Releases
DBV Technologies to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
September 5, 2024
·
2 min read
1 of 35,690
Next
